That means faster immune response, cleaner gene expression, and less chronic inflammation
In vitro studies suggest that extracts or leaves of the M
Transfer 347 , 109631 (2025)
Emibetuzumab (LY2875358) against c-Met and HGF and MP0250 against HGF and VEGF are two bispecific antibodies that prevent c-Met attachment to the ligand, increase the internalization, destroy c-Met molecules, and thereby reduce the signaling of the c-Met pathway [149, 174, 175]
Harford C, Sarkar B
Subsequent research may concentrate on the following aspects: 1) Expansion of ferroptosis research: additional research into the involvement of ferroptosis in OA is essential, especially with critical regulators such as FSP1, DHODH, and GCH1, which remain unexamined in the context of OA